Screen2Quit: An electronic smoking cessation resource for smokers undergoing lung cancer screening.

Not Applicable

Recruiting

• Conditions: nicotine addiction; Lung cancer screening; Mental Health - Addiction; Respiratory - Other respiratory disorders / diseases; Public Health - Health promotion/education; Cancer - Lung - Non small cell; Cancer - Lung - Small cell

• Registration Number: ACTRN12622000990729
• Lead Sponsor: The University of Queensland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-07-14
• Last Update Posted: 29 July 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 690

Inclusion Criteria

Adults smokers who are eligible for lung cancer screening and are able to give informed consent, own a smartphone and a computer, are capable of downloading an app and have access to the internet

Exclusion Criteria

Those who do not own a smartphone and/or do not have access to the internet. Smokers who are current users of a smoking cessation smartphone app.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Self-reported smoking abstinence via questionnaire [ 3 months (primary endpoint) and 12 months post randomisation];Biochemically verified continuous abstinence will be determined using Cotinine measured in urine, or saliva. [ Biochemically verified continuous abstinence will be measured at 3 months and 12 post randomisation. ];Self reported smoking abstinence via questionnaire[ 12 months post randomisation (primary endpoint) ]

Secondary Outcome Measures

Name	Time	Method
ptake, use and acceptability of smartphone app (via the user Mobile App Rating Scale - uMARS)[ 2 weeks, 3 months, 6 months and 12 months post randomisation for those who have interacted with their allocated eResource (app or webpage). The follow up at 2 weeks is to determine if participants have accessed the allocated eResource in the early stages of the study, this is the only information collected at the 2 week time point.];Use of counselling (participant questionnaire designed specifically for this study) [ 3, 6 and 12 months post randomisation];Quit attempts,(participant questionnaire designed specifically for this study)[ 3, 6 and 12 months post randomisation];Change in motivation score (participant questionnaire designed for this study)[ 3, 6 and 12 months post randomisation];Use of pharmacotherapy assessed via questionnaire designed specifically for this study[ 3, 6 and 12 months post randomisation]